chr7-117548758-GAT-G
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000492.4(CFTR):c.1330_1331delAT(p.Ile444fs) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★★). Synonymous variant affecting the same amino acid position (i.e. I444I) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000492.4 frameshift
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CFTR | NM_000492.4 | c.1330_1331delAT | p.Ile444fs | frameshift_variant | Exon 10 of 27 | ENST00000003084.11 | NP_000483.3 | |
| CFTR-AS1 | NR_149084.1 | n.222-6221_222-6220delAT | intron_variant | Intron 2 of 2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Cystic fibrosis Pathogenic:2Other:1
This sequence change creates a premature translational stop signal (p.Ile444*) in the CFTR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CFTR are known to be pathogenic (PMID: 1695717, 7691345, 9725922). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with cystic fibrosis (PMID: 8723695). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as 1460delAT. ClinVar contains an entry for this variant (Variation ID: 53231). For these reasons, this variant has been classified as Pathogenic. -
- -
- -
not specified Pathogenic:1
Variant summary: CFTR c.1330_1331delAT (p.Ile444X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (eg. p.Val456fsX25, p.Ser466X, p.Gly473fsX54). The variant was absent in 238218 control chromosomes (gnomAD). c.1330_1331delAT has been reported in the literature in an individual affected with Cystic Fibrosis (Bienvenu_1996). Despite being located in a region of potential high homology with pseudogenes, one paper reports special PCR methodology to capture only CFTR exon 10, and reports the variant to appear authentic and not an ectopic variant (El Seedy_2013). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Cystic fibrosis;C5924204:CFTR-related disorder Pathogenic:1
the variant causes a phenotype but regarding our data, we can't formally attribute it to CF, CFTR-RD or both -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at